Document
IPR2016-01130, No. 2030-28 Exhibit - Modern Approaches to the Ocular Delivery of Cyclosporine A (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01130, No. 2030-28 Exhibit - Modern Approaches to the Ocular Delivery of Cyclosporine A (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1172-270 Exhibit - Rule 36 Judgment (P.T.A.B. Nov. 21, 2018)
Cite Document
IPR2016-01130, No. 1172-270 Exhibit - Rule 36 Judgment (P.T.A.B. Nov. 21, 2018)
+ More Snippets
Document
IPR2016-01130, No. 2119-276 Exhibit - Docket from CRESPE LLC v Silicon Laboratories Inc (P.T.A.B. Dec. 21, 2018)
Cite Document
IPR2016-01130, No. 2119-276 Exhibit - Docket from CRESPE LLC v Silicon Laboratories Inc (P.T.A.B. Dec. 21, 2018)
+ More Snippets
Document
IPR2016-01130, No. 1075-121 Exhibit - Exhibit 1075 Javadi et al NCBI Dry Eye Syndrome (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01130, No. 1075-121 Exhibit - Exhibit 1075 Javadi et al NCBI Dry Eye Syndrome (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1090-136 Exhibit - Exhibit 1090 Bausch Lotemax (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01130, No. 1090-136 Exhibit - Exhibit 1090 Bausch Lotemax (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1116-162 Exhibit - Exhibit 1116 Restasis Program Benefits (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01130, No. 1116-162 Exhibit - Exhibit 1116 Restasis Program Benefits (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01130, No. 2030-46 Exhibit - The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01130, No. 2030-46 Exhibit - The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01130, No. 2087-258 Exhibit - REDACTED Exhibit 2087 Patent License Agreement (P.T.A.B. Nov. 16, 2017)
Cite Document
IPR2016-01130, No. 2087-258 Exhibit - REDACTED Exhibit 2087 Patent License Agreement (P.T.A.B. Nov. 16, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1152-234 Exhibit - EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01130, No. 1152-234 Exhibit - EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1164-246 Exhibit - Exhibit 1164 Findings of Fact and Conclusions of Law (P.T.A.B. Oct. 18, 2017)
Cite Document
IPR2016-01130, No. 1164-246 Exhibit - Exhibit 1164 Findings of Fact and Conclusions of Law (P.T.A.B. Oct. 18, 2017)
+ More Snippets
Document
IPR2016-01130, No. 1140-208 Exhibit - Declaration of Jennifer A MacLean (P.T.A.B. Sep. 21, 2017)
Cite Document
IPR2016-01130, No. 1140-208 Exhibit - Declaration of Jennifer A MacLean (P.T.A.B. Sep. 21, 2017)
+ More Snippets
Document
IPR2016-01130, No. 2115-262 Exhibit - Eric Donnenfeld MD and Stephen Pflugfelder MD, Topical Ophthalmic Cyclosporine Pharmacology and Clinical Uses, Survey of Ophthalmology, Vol 54, N...
Cite Document
IPR2016-01130, No. 2115-262 Exhibit - Eric Donnenfeld MD and Stephen Pflugfelder MD, Topical Ophthalmic Cyclosporine Pharmacology and Clinical Uses, Survey of Ophthalmology, Vol 54, Number 3, May June
+ More Snippets
Document
IPR2016-01130, No. 1079-125 Exhibit - Exhibit 1079 Mayo Clinic Dry Eyes (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01130, No. 1079-125 Exhibit - Exhibit 1079 Mayo Clinic Dry Eyes (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01130, No. 2012-29 Exhibit - Senile Atrophy of the Human Lacrimal Gland The Contribution of Chronic Inflammatory Disease (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01130, No. 2012-29 Exhibit - Senile Atrophy of the Human Lacrimal Gland The Contribution of Chronic Inflammatory Disease (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01130, No. 2053-63 Exhibit - JP Morgan Equity Research Report (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01130, No. 2053-63 Exhibit - JP Morgan Equity Research Report (P.T.A.B. Mar. 20, 2017)
+ More Snippets